Starting on February 2 2017, Dr. David Caplan and Dr. Jeffrey Ashley are enrolling interested Type 2 diabetic patients who are already on Insulin therapy in a study. This global study examines the potential benefits of a new oral medication for Type 2 diabetic patients on Insulin.
Interested patients must be age over 21, not be pregnant, and have no chronic kidney disease or previous gastrointestinal surgery. Furthermore, the only additional diabetic medication that patients may be taking concurrently with Insulin is Metformin.
If interested please call the office at 416-743-5853.